As oncology care turns to AI-driven imaging, robotic surgery, and targeted drug delivery, robust regulation becomes essential. Chandra Ganjoo, Group CEO, Trivitron Healthcare, explains how clear standards and transparent oversight can protect patients, foster trust, and drive the next wave of cancer-care advancements in India.

Visit Site